"We offer a range of services tailored to your needs."
Radiopharmium provides expert consulting and innovative solutions for the development and production of radiopharmaceuticals.
Consultancy
We provide specialist consultancy across all stages of radiopharmaceutical development - from early research and preclinical studies through to CMC activities that support technology transfer and clinical translation. We also help build strategic collaborations with academic, industry, and healthcare partners to ensure development pipelines progress efficiently and effectively.
Research & Development
Support in early-stage discovery, tracer design, and preclinical evaluation.
CMC
Process development, optimization, and documentation for regulatory readiness.
Clinical Translation
& GMP Production
Guidance on technology transfer, scale-up, and compliance with GMP standards.
Business & Partnership Development
Facilitating collaborations and strategic connections to grow and implement your technology.
For Companies, Startups & Innovators.
We can join your Scientific Advisory Board (SAB), or support your company through Fractional Leadership. Fractional Leadership is ideal for startups and growing organisations at the early stages of their journey. We provide senior-level expertise without the need for a full-time hire. Through our fractional CSO model, you gain flexible, fit-for-purpose scientific leadership tailored to your needs.
- We advise or set scientific strategy - establish a clear R&D roadmap that supports long-term business objectives.
- We drive innovation - identify and advance promising research opportunities with strong translational potential.
- We ensure compliance - oversee regulatory, quality, and documentation requirements to keep development on track.
- We build and lead teams - recruit, mentor, and manage scientific staff to create high-performing teams.
- We secure resources - support fundraising efforts, grant applications, and strategic partnerships to fund R&D.
-
We deliver milestones – manage projects to meet key development goals and provide confidence to investors and stakeholders.
For Funders, Investors & Venture Capitalists.
Radiopharmium helps investors make informed decisions in one of the most complex areas of life sciences. We provide independent scientific and technical due diligence, assessing the strengths, risks, and opportunities of potential investments. Our expertise bridges the gap between innovation and clinical application, giving you confidence that portfolio companies are built on sound science and realistic development pathways.
- Protect your capital - with rigorous scientific and technical due diligence.
- Reduce risk - by identifying regulatory, clinical, and operational challenges early.
- Strengthen your portfolio - through independent reviews that highlight gaps and opportunities.